Back
Oct 01
Quick Pitch
QP 23 - GI 5: Quick Pitch: ROTF LMAO with pancreatic and liver - Recurrences and Outcomes, Technological Feats, Latest Modalities, and Adapting Online
MODERATOR(S)
Dawn Owen, MD, PhD - Mayo Clinic Rochester
Credits
AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
10:30am - 11:30am PT
GI 5: Quick Pitch: ROTF LMAO with pancreatic and liver - Recurrences and Outcomes, Technological Feats, Latest Modalities, and Adapting Online
Speaker: Jelena Lukovic, MD - Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Canada, Toronto -
10:30am - 11:30am PT
GI 5: Quick Pitch: ROTF LMAO with pancreatic and liver - Recurrences and Outcomes, Technological Feats, Latest Modalities, and Adapting Online
Speaker: Michael Chuong, MD - Miami Cancer Institute at Baptist Health South Florida, Miami -
10:35am - 10:40am PT
CT-Guided Online Adaptive Stereotactic Body Radiotherapy for Pancreas Ductal Adenocarcinoma: Early Outcomes and Toxicity Data
Speaker: Albert Lee, MD - Columbia University Irving Medical Center, New York -
10:40am - 10:45am PT
First Clinical Results of Carbon Ion Therapy for Pancreatic Cancer in Taiwan: Insights into Efficacy and Side Effects
Speaker: I-Chun Lai, MD, PhD - Taipei Veterans General Hospital, Taipei -
10:45am - 10:50am PT
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients with Unresectable and Borderline Resectable Pancreatic Cancer
Speaker: Uri Amit, MD, PhD, MPH - Tel Aviv Medical Center, Tel Aviv -
10:55am - 11:00am PT
Stereotactic Body Radiation Therapy versus Surgical Resection for BCLC Stage 0 Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis
Speaker: Hye In Lee, MD - Asan Medical Center, Seoul -
11:00am - 11:05am PT
Impact of Baseline Liver Function on Survival Outcomes Following Initial SBRT vs SBRT Re-Irradiation for Hepatocellular Carcinoma: An Albumin-Bilirubin Grade Analysis
Speaker: Daisuke Nakamura, MD, PhD - Nagasaki University Hospital, Nagasaki -
10:50am - 10:55am PT
Salvage Adaptive Radiation Therapy for Locoregional Recurrence of Pancreatic Adenocarcinoma
Speaker: Michael Padgett, MD - Washington University in St. Louis, St. Louis